The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Profound Medical's share price is $7.43.
Profound Medical's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.38. Hence, Profound Medical's PS Ratio for today is 19.60.
Good Sign:
Profound Medical Corp stock PS Ratio (=20.82) is close to 2-year low of 19.63
The historical rank and industry rank for Profound Medical's PS Ratio or its related term are showing as below:
PROF'
s PS Ratio Range Over the Past 10 Years
Min: 10.32 Med: 28.53 Max: 94.39
Current: 20.66
During the past 10 years, Profound Medical's highest PS Ratio was 94.39. The lowest was 10.32. And the median was 28.53.
PROF's PS Ratio is ranked worse than 92.42% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 3.3
vs PROF: 20.66
Profound Medical Corp revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Profound Medical was 24.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -5.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 6.70% per year.
During the past 10 years, Profound Medical's highest 3-Year average Revenue per Share Growth Rate was 18.90% per year. The lowest was -12.60% per year. And the median was -4.80% per year.
Back to Basics: PS Ratio
Profound Medical PS Ratio Historical Data
The historical data trend for Profound Medical's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Profound Medical's PS Ratio
For the Medical Devices subindustry, Profound Medical's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Profound Medical's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's PS Ratio distribution charts can be found below:
* The bar in red indicates where Profound Medical's PS Ratio falls into.
Profound Medical PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Profound Medical's Share Price of today is $7.43. Profound Medical's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.38.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Profound Medical PS Ratio Related Terms
Thank you for viewing the detailed overview of Profound Medical's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PROF has been successfully added to your 